Spectrum bladder cancer drug not effective - U.S. FDA panel

Sept 14 (Reuters) - Spectrum Pharmaceuticals Inc's

experimental bladder cancer treatment apaziquone is not

effective in delaying the time to recurrence of the disease, an

advisory committee to the U.S. Food and Drug Administration

concluded on Wednesday.

Read more